SWM
IMGN

SeaCrest Wealth Management’s Immunogen Inc IMGN Stock Holding History

SeaCrest Wealth Management’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-3,625
Closed -$16K – 1601
2022
Q2 		$16K Buy
+3,625
New +$15.7K ﹤0.01% 1586
2019
Q2 		– Sell
-2,300
Closed -$6K – 1953
2019
Q1 		$6K Hold
2,300
– – ﹤0.01% 1689
2018
Q4 		$11K Sell
2,300
-2,548
-53% -$15.5K ﹤0.01% 1477
2018
Q3 		$46K Hold
4,848
– – 0.01% 1045
2018
Q2 		$47K Buy
4,848
+229
+5% +$2.41K 0.01% 1021
2018
Q1 		$49K Sell
4,619
-1,271
-22% -$12.6K 0.01% 963
2017
Q4 		$38K Buy
+5,890
New +$36.3K 0.01% 1078

Other funds holding IMGN

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

SeaCrest Wealth Management's IMGN Position: Q3 2022 in Review

SeaCrest Wealth Management sold out of Immunogen Inc (IMGN) in Q3 2022, closing a stake of 3,625 shares — an estimated $16K sold.

SeaCrest Wealth Management first reported a position in IMGN in Q4 2017 and held it in 7 quarters. The position peaked at $49K in Q1 2018. 222 funds tracked by Wall St. Rank hold IMGN as of Q3 2022.

  • SeaCrest Wealth Management reported no remaining Immunogen Inc position as of Q3 2022 after selling out during the quarter.
  • SeaCrest Wealth Management sold 3,625 Immunogen Inc shares in Q3 2022, an estimated $16K.
  • SeaCrest Wealth Management first reported a position in Immunogen Inc in Q4 2017 and held it in 7 quarters.
  • SeaCrest Wealth Management's Immunogen Inc position peaked at $49K in Q1 2018.
  • 222 funds tracked by Wall St. Rank held Immunogen Inc as of Q3 2022.

Based on SeaCrest Wealth Management's 13F filing for Q3 2022, filed 15 Nov 2022.